Compare Norwegian Cruise Line Holdings Ltd (NCLH) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norwegian Cruise Line Holdings Ltd vs Revvity Inc — how do they compare? Norwegian Cruise Line Holdings Ltd trades at $19.42 (market cap $8.95B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.26% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals.
| NCLH | RVTY | |
|---|---|---|
Market Cap | $8.95B | $11.87B |
Sector | Consumer Cyclical | Technology |
52-Week High | $26.94 | $117.75 |
52-Week Low | $14.79 | $82.26 |
Enterprise Value | $23.92B | $14.36B |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
